Erste Asset Management’s Axsome Therapeutics AXSM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.77M	Hold	11,000	–	–	0.02%	379
2025 Q4	$1.66M	Hold	11,000	–	–	0.01%	376
2025 Q3	$1.29M	Hold	11,000	–	–	0.01%	387
2025 Q2	$1.14M	Hold	11,000	–	–	0.01%	485
2025 Q1	$1.3M	Hold	11,000	–	–	0.02%	349
2024 Q4	$954K	Hold	11,000	–	–	0.01%	393
2024 Q3	$986K	Hold	11,000	–	–	0.01%	386
2024 Q2	$881K	Hold	11,000	–	–	0.01%	383
2024 Q1	$871K	Hold	11,000	–	–	0.01%	376
2023 Q4	$876K	Hold	11,000	–	–	0.01%	376
2023 Q3	$804K	Hold	11,000	–	–	0.01%	367
2023 Q2	$804K	Hold	11,000	–	–	0.01%	379
2023 Q1	$666K	Hold	11,000	–	–	0.01%	399
2022 Q4	$842K	Buy	+11,000	New	+$657K	0.02%	377
2022 Q2	–	Sell	-11,000	Closed	-$440K	–	602
2022 Q1	$440K	Hold	11,000	–	–	0.01%	449
2021 Q4	$391K	Buy	+11,000	New	+$405K	0.01%	443
2021 Q1	–	Sell	-11,500	Closed	-$946K	–	530
2020 Q4	$946K	Hold	11,500	–	–	0.03%	342
2020 Q3	$831K	Hold	11,500	–	–	0.03%	314
2020 Q2	$878K	Hold	11,500	–	–	0.04%	301
2020 Q1	$662K	Buy	+11,500	New	+$937K	0.04%	286